Compound Detail
CHEMBL1093231
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1093231 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RLYKRTXCPRRQST-UHFFFAOYSA-N |
5
Targets
5
Activities
2
Assay Types
0
PK Parameters
16
Publications
0
Known Names
Molecular Properties
220.3
MW (Da)
1.86
ALogP
5
HBA
2
HBD
63.8
PSA (Ų)
0.57
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 4.67
EC50 1 meas. best 4.64
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Trypanosoma cruzi CHEMBL368 | IC50 | 4.67 | 4.67 | 21300.0 | 1 |
| Hepatitis C virus CHEMBL379 | EC50 | 4.64 | 4.64 | 23100.0 | 1 |
| ADMET CHEMBL612558 | IC50 | 4.47 | 4.47 | 33800.0 | 1 |
| Vero CHEMBL391 | IC50 | 4.39 | 4.39 | 40900.0 | 1 |
| Leishmania amazonensis CHEMBL612877 | IC50 | 4.26 | 4.26 | 54400.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Trypanosoma cruzi | IC50 | = | 21300.0 | nM | 4.67 | Antitrypanosomal activity against Trypanosoma cruzi tulahuen C4 trypomastigotes ... | 20356752 |
| Hepatitis C virus | EC50 | = | 23100.0 | nM | 4.64 | Antiviral activity against Hepatitis C virus genotype 1b infected in human HuH5.... | 27474921 |
| ADMET | IC50 | = | 33800.0 | nM | 4.47 | Cytotoxicity against BALB/c mouse macrophages after 48 hrs by trypan blue dye ex... | 20356752 |
| Vero | IC50 | = | 40900.0 | nM | 4.39 | Cytotoxicity against african green monkey Vero cells after 72 hrs by MTS assay | 20356752 |
| Leishmania amazonensis | IC50 | = | 54400.0 | nM | 4.26 | Antileishmanial activity against Leishmania amazonensis MHOM/BR/76/LTB-012 amast... | 20356752 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20356752 | 10.1016/j.bmc.2010.03.018 | Unchecked | 3 |
| 27474921 | 10.1016/j.ejmech.2016.07.035 | Hepatitis C virus | 2 |
| 20356752 | 10.1016/j.bmc.2010.03.018 | Trypanosoma cruzi | 1 |
| 20356752 | 10.1016/j.bmc.2010.03.018 | Mycobacterium tuberculosis | 1 |
| 20356752 | 10.1016/j.bmc.2010.03.018 | Leishmania amazonensis | 1 |
| 20356752 | 10.1016/j.bmc.2010.03.018 | NIH3T3 | 1 |
| 20356752 | 10.1016/j.bmc.2010.03.018 | NCI-H460 | 1 |
| 20356752 | 10.1016/j.bmc.2010.03.018 | DU-145 | 1 |
| 20356752 | 10.1016/j.bmc.2010.03.018 | MCF7 | 1 |
| 20356752 | 10.1016/j.bmc.2010.03.018 | M14 | 1 |
| 20356752 | 10.1016/j.bmc.2010.03.018 | HT-29 | 1 |
| 20356752 | 10.1016/j.bmc.2010.03.018 | K562 | 1 |
| 20356752 | 10.1016/j.bmc.2010.03.018 | Vero | 1 |
| 20356752 | 10.1016/j.bmc.2010.03.018 | ADMET | 1 |
| 27474921 | 10.1016/j.ejmech.2016.07.035 | NON-PROTEIN TARGET | 1 |
| 27474921 | 10.1016/j.ejmech.2016.07.035 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine